IMR Press / CEOG / Volume 41 / Issue 4 / DOI: 10.12891/ceog16712014

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Serum levels of androgens and prostate-specific antigen in endometriosis
Show Less
1 Dicle University, School of Medicine, Department of Obstetrics and Gynecology, Diyarbakir
2 Karadeniz Technical University, School of Medicine, Department of Obstetrics and Gynecology, Trabzon
3 Dicle University, School of Medicine, Department of Urology, Diyarbakir
4 Dicle University, School of Medicine, Department of Medical Biochemistry, Diyarbakir (Turkey)
Clin. Exp. Obstet. Gynecol. 2014, 41(4), 432–435; https://doi.org/10.12891/ceog16712014
Published: 10 August 2014
Abstract

Objective: The aim of the present study was to evaluate the levels of serum androgens and prostate-specific antigen (PSA) levels in patients with endometriosis. Materials and Methods: Patients with Stage III/IV(advanced stage) endometriosis were compared to controls with respect to basal serum levels of total testosterone (T), free testosterone (fT), androstenedion (A), dehydroepiandrosterone (DHEA), dehydroepiandrosterone-sulphate (DHEA-S), and PSA in the early follicular phase of menstrual cycle for this prospective case control study. Results: Level of T, fT, A, DHEA, and DHEA-S were higher in patients with endometriosis when compared to control subjects, but the difference was not statistically significant. The mean PSA level was 0.0074 ± 0.0120 ng/ml in patients with endometriosis and 0.0059 ± 0.0056 ng/ml in control group and there was no statistically significant difference between groups (p = 0.58). Conclusion: Serum basal androgens and PSA levels are higher in endometriosis group with respect to control but the differences are not statistically significant.
Keywords
Endometriosis
Androgens
Prostate-specific antigen
Share
Back to top